Similar Papers

Paper Title
Journal
Date
Author
Sustained Enzymatic Correction by rAAV-Mediated Liver Gene Therapy Protects Against Induced Motor Neuropathy in Acute Porphyria Mice
Carmen Unzu ... Antonio Fontanellas
Molecular Therapy | VOL. 19
Carmen Unzu, et. al.Carmen Unzu ... Antonio Fontanellas
01 Feb 2011
The effect of therapeutic drugs and other pharmacologic agents on activity of porphobilinogen deaminase, the enzyme that is deficient in intermittent acute porphyria
Peter V Tishler
Life Sciences | VOL. 65
Peter V TishlerPeter V Tishler
01 Jun 1999
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification.
Amy Chan ... Robert J Desnick
Molecular Therapy - Nucleic Acids | VOL. 4
Amy Chan, et. al.Amy Chan ... Robert J Desnick
01 Jan 2015
Disease pharmacokinetic-pharmacodynamic modelling in acute intermittent porphyria to support the development of mRNA-based therapies.
Zinnia P Parra-Guillen ... Iñaki F Troconiz
British journal of pharmacology | VOL. 177
Zinnia P Parra-Guillen, et. al.Zinnia P Parra-Guillen ... Iñaki F Troconiz
14 Apr 2020
View more papers

More From: Gut

Paper Title
Journal
Date
Author
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
Panagiota Maravelia ... Anna Pasetto
Gut | VOL. -
Panagiota Maravelia, et. al.Panagiota Maravelia ... Anna Pasetto
18 Jan 2025
GI highlights from the literature
Philip J Smith
Gut | VOL. 74
Philip J SmithPhilip J Smith
17 Jan 2025
Correction: Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis
-
Gut | VOL. 74
--
17 Jan 2025
Targeting MXD1 sensitises pancreatic cancer to trametinib
Shaoping Zhang ... Xudong Huang
Gut | VOL. -
Shaoping Zhang, et. al.Shaoping Zhang ... Xudong Huang
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.